Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Notes Payable

Notes Payable

3 Months Ended

Mar. 31, 2015

7. Notes Payable

In 2012, the Company entered into a note agreement in conjunction with its lease agreement for our Richmond, California facility. The note for an aggregate $200, with an interest rate of 7%, minimum monthly payments of $4, and a May 31, 2017 maturity, was used to fund leasehold improvements. In addition, the Company has a long-term capital lease obligation of $12.

Future obligations under these debt instruments as of March 31, 2015 are as follows:

				Leasehold
	Capital			Improvement
	Lease			Note			Total
2015 (remainder)	$	4		$	36		$	40
2016		5			48			53
2017		4			19			23
Total minimum lease payments		13			103			116
Less: interest		(1	)		(8	)		(9	)
Present value minimum lease payments		12			95			107
Less: current portion		-			(42	)		(42	)
Long-term portion of capital lease obligation	$	12		$	53		$	65

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References + Details